|
Tissue Regenix Group PLC - Leeds, England-based medical device company - Launches Vnew Fascia Lata allograft as an additional line extension in dCell division. Says the Vnew Fascia Lata is a soft tissue allograft used to support weakened tissue that can result in stress urinary incontinence, which affects around one-third of adult women at some point in their lives.
Chief Executive Officer Daniel Lee says: ‘The diversification of our product portfolio will contribute to our market penetration, as well as provide a significant improvement to quality of life for those patients that receive these allografts.’
Current stock price: 0.57 pence, down 2.2% on Wednesday in London
12-month change: up 14%
By Xindi Wei, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2022 Alliance News Ltd. All Rights Reserved.
|
